Sotera Health Co (SHC)

Gross profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Gross profit (ttm) US$ in thousands 571,146 571,163 559,123 561,337 561,457 538,795 528,824 539,632 557,004 549,237 538,810 532,175 518,672 505,296 487,221 462,427 443,572 420,216 412,949 392,965
Revenue (ttm) US$ in thousands 1,100,441 1,120,477 1,098,186 1,076,874 1,049,288 990,639 976,166 987,523 1,003,687 993,346 970,806 956,084 931,478 907,074 880,938 842,106 818,158 794,798 790,092 771,767
Gross profit margin 51.90% 50.97% 50.91% 52.13% 53.51% 54.39% 54.17% 54.65% 55.50% 55.29% 55.50% 55.66% 55.68% 55.71% 55.31% 54.91% 54.22% 52.87% 52.27% 50.92%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $571,146K ÷ $1,100,441K
= 51.90%

Sotera Health Co's gross profit margin has shown fluctuation over the past few years, starting at 50.92% as of March 31, 2020, and gradually increasing to a peak of 55.71% as of September 30, 2021. Subsequently, there was a slight decline in the margin but it remained relatively stable around the mid-50% range until December 31, 2023. From there, the gross profit margin began to decline, reaching 51.90% as of December 31, 2024.

Overall, Sotera Health Co's gross profit margin trended upwards initially, indicating an improvement in the efficiency of its production process and cost management. However, the subsequent decline could suggest potential challenges in maintaining profitability or controlling costs effectively. It may be important for the company to assess its cost structure and operational efficiency to sustain profitability in the future.


Peer comparison

Dec 31, 2024

Company name
Symbol
Gross profit margin
Sotera Health Co
SHC
51.90%
DaVita HealthCare Partners Inc
DVA
82.35%
Progyny Inc
PGNY
21.70%